These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5746328)

  • 21. Viscoelastic effects of dextran 70 on human blood.
    Caprini JA; Zuckerman L; Wright SK; Vagher JP; Kwaan HC
    Surg Forum; 1979; 30():491-3. PubMed ID: 538673
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activation of the fibrinolytic system by low-molecular dextran].
    Fischer M; Wimmer H
    Bibl Haematol; 1965; 23():1278-83. PubMed ID: 5885216
    [No Abstract]   [Full Text] [Related]  

  • 23. Fibrinogen degradation products in experimental intravascular coagulation. Gel filtration and immunological studies.
    Zetterqvist E
    Acta Physiol Scand; 1971 Jul; 82(3):289-99. PubMed ID: 4108400
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of oestriol on platelet adhesiveness and fibrinolysis in men.
    Bennett NB; Bennett PN; Fullerton HW; Ogston CM; Ogston D
    Lancet; 1966 Oct; 2(7469):881-2. PubMed ID: 4162295
    [No Abstract]   [Full Text] [Related]  

  • 25. On the lysis of fibrin formed in the presence of dextran and other macromolecules.
    Wallenbeck IA; Tangen O
    Thromb Res; 1975 Jan; 6(1):75-86. PubMed ID: 123094
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of thrombotic diseases.
    Douglas AS
    Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of low molecular weight dextran on acrocyanosis and scleroderma.
    Zackheim HS; Farber EM; Aschheim E
    Dermatologica; 1969; 139(2):145-53. PubMed ID: 5810899
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experiences with dextran treatment.
    Sawyer RB
    Acta Chir Scand Suppl; 1968; 387():58-60. PubMed ID: 5256245
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of iodinated roentgen contrast media on coagulation, fibrinolysis and platelets].
    Schulze B; Riester P; Blanke D; Fees K; Lehnard G
    Arzneimittelforschung; 1977; 27(11):2128-33. PubMed ID: 580014
    [No Abstract]   [Full Text] [Related]  

  • 30. Urokinase-induced fibrinolysis of 125-I-fibrin. Conditions for first-order activation kinetics, density-gradient separation of split products, and a microassay.
    Ball AP; Day ED
    Thromb Diath Haemorrh; 1970 Dec; 24(3):463-74. PubMed ID: 5503943
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of dextran 40,000 on the dynamics of blood clotting in thromboelastographic studies].
    Sulek K
    Pol Tyg Lek; 1971 Apr; 26(14):497-9. PubMed ID: 5574220
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of pyridinolcarbamate (anginin) on blood coagulation, fibrinolysis and thrombocytes].
    Goossens N
    Thromb Diath Haemorrh Suppl; 1973; 55():273-84. PubMed ID: 4804076
    [No Abstract]   [Full Text] [Related]  

  • 34. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP
    J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antithrombin and antiplasmin effect of 4-amidinophenylpyruvic acid in vivo].
    Markwardt F; Klöcking HP; Nowak G
    Thromb Diath Haemorrh; 1970 Oct; 24(1):240-7. PubMed ID: 5483964
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of low molecular weight dextran on circulatory dynamics and oxygen consumption in experimental hemorrhagic shock.
    Smith LL; Staehelin HB; Jolley WB
    Surgery; 1969 Oct; 66(4):782-9. PubMed ID: 5822770
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1969 Mar; 81(3):220-5. PubMed ID: 5775073
    [No Abstract]   [Full Text] [Related]  

  • 38. Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.
    Zetterqvist E
    Acta Physiol Scand Suppl; 1969; 325():1-41. PubMed ID: 4900570
    [No Abstract]   [Full Text] [Related]  

  • 39. New aspects of the therapeutic influence of sludging in internal diseases and some critical remarks concerning the effectiveness of low molecular weight dextran.
    Böhme H
    Bibl Anat; 1973; 12():345-50. PubMed ID: 4597633
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of dextran 150 on the early phase of coagulation. 3. In vivo studies on rabbits. Readiness for agglutination of thrombocytes, properties on the inhibitor].
    Kuhn W; Immich H; Schulz H; Dehnen E; Ghambir RC; Graeff H
    Klin Wochenschr; 1967 Apr; 45(8):404-9. PubMed ID: 5596462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.